UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Israel Chemicals Ltd.
(Exact name of registrant as specified in its charter)
|
Israel |
|
Not Applicable |
|
(State of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
Millennium Tower |
|
Not Applicable |
|
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Name of each exchange on which |
|
|
|
|
|
Ordinary shares, par value NIS 1 per share |
|
New York Stock Exchange |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o
Securities Act registration statement file number to which this form relates: 333-198711
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1: Description of Registrant’s Securities to be Registered
The description of the securities to be registered will be contained in a prospectus, constituting part of the Registrant’s Registration Statement on Form F-1 (Registration No. 333-198711) relating to such securities, to be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as filed pursuant to Rule 424(b), the “Prospectus”). The description of the securities contained in the Prospectus is hereby incorporated by reference into this Form 8-A.
Item 2: Exhibits
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on the New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of the Exchange Act.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
Israel Chemicals Ltd. | ||
|
|
| ||
|
|
| ||
|
|
By: |
/s/ Avi Doitchman | |
|
|
|
Name: |
Avi Doitchman |
|
|
|
Title: |
Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
Israel Chemicals Ltd. | ||
|
|
| ||
|
|
| ||
|
|
By: |
/s/ Lisa Haimovitz | |
|
|
|
Name: |
Lisa Haimovitz |
|
|
|
Title: |
VP General Counsel and Company Secretary |
Date: September 17, 2014